GE HealthCare wins FDA 510(k) for Genesis Radiology Workspace (View) and showcased AI-driven imaging and health IT at HIMSS 2026. What this means for radiology workflows.
EMA and FDA publish joint principles for safe AI across the medicines lifecycle, guiding risk-based validation, data governance, human oversight and patient safety.
Global Standards for AI in Drug Discovery: EMA and FDA Principles Read More »
How healthcare reforms, genomics programs, and policy shifts are accelerating AI adoption in care delivery, data governance, and population health.
AI’s Strategic Integration in Healthcare: Trends from Policy to Genomics Read More »
A concise look at how AI is accelerating drug discovery, refining diagnostics, and enabling personalized medicine with examples from AlphaFold and generative drug design.
AI Biotechnology Breakthroughs: How AI Is Reshaping Drug Discovery and Care Read More »
A concise guide for health leaders on practical steps to build a people-centred, trustworthy AI system across UK health and social care.
AI in UK Healthcare: Practical Steps for a People-Centred System Read More »
NHS RSET real-world evaluation of AI in chest X-rays: faster prioritisation, positive staff and patient views, cost-effectiveness, but implementation and data gaps.
Real-World AI in Chest Diagnostics: NHS RSET Evaluation and Key Lessons Read More »
A concise overview of how AI is transforming diagnostics, drug development and clinical workflows, alongside the ethical, privacy and regulatory steps needed.
AI in Healthcare: Promise, Peril, and a Roadmap for Responsible Use Read More »
Google’s AMIE study shows conversational diagnostic AI gathers histories, matches clinician-level top diagnoses, raises patient trust, and operates safely with physician oversight.
Real-World Study Validates Conversational AI for Diagnostic Care Read More »
Discover how AI paired with fiber, mobile and satellite connectivity is making care proactive, accessible and personalized for patients and communities worldwide.
AI and Connectivity: Reshaping Proactive Healthcare and Social Well-being Read More »
A concise overview of Europe’s AI-driven drug discovery market: market trajectory, key technologies, leading countries, main challenges, and strategic opportunities.
Europe’s AI Drug Discovery Surge: Trends, Players, and What’s Next Read More »
